Key findings included: Weight loss of up to 24.2% of body weight at 48 weeks this figure was observed in adults without type 2 diabetes receiving the highest dose with a protocolised titration schedule
The Health Belief Model explains that people are more likely to take action when they: Believe they are personally at risk Believe the condition has serious consequences Believe the benefits of action outweigh the barriers Feel confident they can successfully take that action Now, apply this to our context
In addition, the compact format supports easier storage and transport within professional research settings
coverage for seniors and income-based programs | | Quebec | Covered (RAMQ) | Type 2 diabetes, failed on other oral agents | Exception Drug | Covered under RAMQ public plan with medication d'exception status | | Manitoba | Covered (Pharmacare) | Type 2 diabetes | Exception Drug Status | Income-based deductible applies before coverage kicks in | | Saskatchewan | Covered (Drug Plan) | Type 2 diabetes, inadequate control | Exception Drug Status | Requires Exception Drug Status application | | Nova Scotia | Covered (Pharmacare) | Type 2 diabetes | Exception Status | Programs for seniors and income assistance recipients | | New Brunswick | Covered (Drug Plans) | Type 2 diabetes | Special Authorization | Available through NB Drug Plan | | Prince Edward Island | Covered (Drug Programs) | Type 2 diabetes | Special Authorization | Limited to eligible program participants | | Newfoundland and Labrador | Covered (NLPDP) | Type 2 diabetes | Special Authorization | Newfoundland and Labrador Prescription Drug Program | | Northwest Territories | Covered (NIHB/EHB) | Type 2 diabetes | Special Authorization | Extended Health and Social Services | | Nunavut | Covered (NIHB/EHB) | Type 2 diabetes | Approval required | Limited coverage programs | | Yukon | Covered (Drug Programs) | Type 2 diabetes | Approval required | Pharmacare and chronic disease programs | A pattern emerges: every province covers Ozempic for type 2 diabetes, but not one covers it purely for weight management through public drug plans as of early 2026
Side effect profiles The most notable difference: injection site reactions do not apply to the ODT
Final Thoughts: Where to Inject Peptides Understanding where to inject peptides can make peptide therapy feel less intimidating and help support a more comfortable treatment experience
